Clearside “Tybee” CLS1004-201

Status: Currently enrolling

ClinicalTrials.gov Identifier: NCT03126786

CLS1004-201: A Phase II, randomized, masked, controlled trial to study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunction with Intravitreal Aflibercept in patients with Diabetic Macular Edema.

Condition: Diabetic Macular Edema

Study Type: Interventional

Duration: 24 weeks

Eligibility:

  • Ages: 18 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.